JEFFREY M LEIDEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY M LEIDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY M LEIDEN. JEFFREY M LEIDEN is a President & COO in ABBOTT LABORATORIES ($ABT) and a President and COO in ABBOTT LABORATORIES ($ABT) and a CEO & President in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and an Executive Chairman in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a Director in QUEST DIAGNOSTICS INC ($DGX).
Address: 100 ABBOTT PARK ROAD ABBOTT PARK 60064-6400 IL
Companies in which JEFFREY M LEIDEN is an Insider
ABBOTT LABORATORIES
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY M LEIDEN: President and COO, President & COO
Holdings: 209,401 shares
Current Value: $8,981,209
Latest Transaction: Mar 28 2006
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
QUEST DIAGNOSTICS INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of JEFFREY M LEIDEN: Director
Holdings: 6,000 shares
Current Value: $555,720
Latest Transaction: May 30 2018
$DGX Market Capitalization: $12.75B
$DGX Previous Close: $92.62
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY M LEIDEN: Executive Chairman, CEO & President
Holdings: 33,809 shares
Current Value: $2,935,974
Latest Transaction: Feb 05 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JEFFREY M LEIDEN
Sentiment: All, ABT, DGX, VRTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Payment of Exercise | F | 215.03 | 8,599 | 1,849,043 | 77,600 | 86.2 K to 77.6 K (-9.98 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 20,928 | 0 | 86,199 | 65.3 K to 86.2 K (+32.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,462 | 0 | 65,271 | 33.8 K to 65.3 K (+93.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,498 | 0 | 33,809 | 2.3 K to 33.8 K (+1,362.96 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Payment of Exercise | F | 215.03 | 8,599 | 1,849,043 | 77,600 | 86.2 K to 77.6 K (-9.98 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 20,928 | 0 | 86,199 | 65.3 K to 86.2 K (+32.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,462 | 0 | 65,271 | 33.8 K to 65.3 K (+93.06 %) |